- Home
- VSH vs CNTA Comparison
VSH vs CNTA Comparison
Compare VSH & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSH
- CNTA
- Stock Information
- Founded
- VSH 1962
- CNTA 2020
- Country
- VSH United States
- CNTA United Kingdom
- Employees
- VSH N/A
- CNTA N/A
- Industry
- VSH Electrical Products
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- VSH Technology
- CNTA Health Care
- Exchange
- VSH Nasdaq
- CNTA Nasdaq
- Market Cap
- VSH 2.2B
- CNTA 2.2B
- IPO Year
- VSH N/A
- CNTA 2021
- Fundamental
- Price
- VSH $17.04
- CNTA $16.47
- Analyst Decision
- VSH Buy
- CNTA Strong Buy
- Analyst Count
- VSH 3
- CNTA 8
- Target Price
- VSH $22.00
- CNTA $23.17
- AVG Volume (30 Days)
- VSH 1.9M
- CNTA 1.0M
- Earning Date
- VSH 02-05-2025
- CNTA 03-27-2025
- Dividend Yield
- VSH 2.32%
- CNTA N/A
- EPS Growth
- VSH N/A
- CNTA N/A
- EPS
- VSH N/A
- CNTA N/A
- Revenue
- VSH $2,937,587,000.00
- CNTA $6,853,000.00
- Revenue This Year
- VSH $4.58
- CNTA N/A
- Revenue Next Year
- VSH $8.79
- CNTA N/A
- P/E Ratio
- VSH N/A
- CNTA N/A
- Revenue Growth
- VSH N/A
- CNTA N/A
- 52 Week Low
- VSH $14.95
- CNTA $7.75
- 52 Week High
- VSH $24.69
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- VSH 45.45
- CNTA 50.60
- Support Level
- VSH $16.39
- CNTA $15.30
- Resistance Level
- VSH $17.86
- CNTA $17.29
- Average True Range (ATR)
- VSH 0.73
- CNTA 1.14
- MACD
- VSH -0.08
- CNTA 0.03
- Stochastic Oscillator
- VSH 19.01
- CNTA 69.29
About VSH Vishay Intertechnology Inc.
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer worldwide. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.